Pharmaceutical Anti-Counterfeiting
The scourge of counterfeit drugs poses an ever-increasing threat to the global healthcare system. The problem is not limited to internet pharmacies or developing countries but has the potential to affect all of us. Fighting back against fake and diverted medicines requires a mix of laws, processes and technologies, underpinned by a sound understanding of the strategic principles.
There are already a number of major initiatives to increase the traceability of drugs and improve supply chain security, such as serialization, e-pedigree, SMS verification etc. Some of these will become mandatory requirements (for example in Europe and California) within a few years. Individual companies also put security features on their packaging to aid in the authentication of their products when suspected fake drugs are identified. The number of technology options and legal obligations can be confusing and clear guidance has been hard to come by.
With "Pharmaceutical Anti-Counterfeiting," Pharmaceutical consultant Mark Davison, CEO of Blue Sphere Health has written a comprehensive guide for drug company executives, technology vendors, healthcare professionals and policy-makers. The book covers the key concepts and explains the available options in pharmaceutical anti-counterfeiting including a mix of policy, strategy, tactics and practical implementation tips
Mark Davison
Pharmaceutical Anti-Counterfeiting
John Wiley & Sons
€77.90
2011, 426 pages, hardcover
ISBN: 978-0-470-61617-8
Win a Copy of Mark Davison's Book!
"Pharmaceutical Anti-Counterfeiting" covers the key concepts and explains the available options in pharmaceutical anti-counterfeiting including a mix of policy, strategy, tactics and practical implementation tips. A must-read for those determined to do something about counterfeit pharmaceutical and healthcare products, and will prove useful to brand protection professionals in other industries.
To register to win a free copy, send an email with your business mailing address to CHEManager-Europe@gitverlag.com by Monday, Feb. 27!
